We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Prophotonix Limited | LSE:PPIX | London | Ordinary Share | COM SHS $0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.75 | 8.50 | 9.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/8/2020 16:25 | Pugugly: you really have it in for PPIX don't you? I was concerned when I first saw it but it just seems like an overly cautious statement by the auditors. It is priced to go bust now anyway so surely the only way is up, if it isn't actually in trouble, which the cash suggests they are not. | joerog | |
27/8/2020 09:51 | Looks like a dead cat bounce (imo) A continuous loss maker - Could it be that Miton are uing this spike to rescue some of their cash? Now valued at far less than many flats or mews houses in Central London - If there was any value here I would have expected it to have been taken private. As no apparent approach message received is that no value seen - | pugugly | |
27/8/2020 06:32 | Could this be the end of the road approaching? "Shareholders are advised that the Auditors Opinion, while unqualified, contains a material uncertainty as to going concern, due to the matters disclosed in note 1 to the financial statements. The details of the Auditors Opinion are contained the Annual Report and Accounts which will be available on the Company's website." | pugugly | |
29/7/2020 01:40 | POST REMOVED | buywell3 | |
28/7/2020 06:37 | Not wishing to be pessimistic but in the comments section of article: There is detailed evidence that the strength of 222nm u/v needed to kill covid is also damaging to live tissue. | rburtn | |
27/7/2020 07:27 | Lol. Dr Biotech notes that Buywell2/3/4 was recently saying that 5G was dangerous. It now seems that Buywell thinks irradiating the body with a much more intense UV light would be a good thing. Dr Biotech thinks that Buywell2/3/4 really hasn’t got a clue. Dr Biotech hopes that Buywell2/3/4 won’t post his many lies any more, but given his multiple aliases thinks it’s unlikely. | dr biotech | |
27/7/2020 02:25 | POST REMOVED | buywell3 | |
27/7/2020 00:09 | POST REMOVED | buywell3 | |
24/7/2020 11:52 | Falling back burning fingers? - Could Buybad3/4 pump be the reason? | pugugly | |
24/7/2020 06:48 | Now that is interesting - Buywell3/4 ramps up posting and at the same time Miton start dumping Hummmmmmmmmmmmmmmmm. ???????????????????? | pugugly | |
24/7/2020 06:12 | Miton dumping their holding. They were the largest institutional holding too. | dr biotech | |
23/7/2020 23:00 | POST REMOVED | buywell3 | |
23/7/2020 22:41 | POST REMOVED | buywell3 | |
23/7/2020 18:33 | .05p- Never made a profit for at least 5 years - Should really be taken private - Buywell3/4 - If you are that keen why not have a whip round and put in an offer? | pugugly | |
23/7/2020 18:33 | Its a £1m market cap company. Its either bust or a multibagger, place your bets. | spooky | |
23/7/2020 18:26 | Buywell thinks second wave coming. FTSE 4000, this to 0.1p. What price capital raise? | buywell4 | |
23/7/2020 15:19 | POST REMOVED | buywell3 | |
23/7/2020 09:31 | POST REMOVED | buywell3 | |
23/7/2020 09:01 | POST REMOVED | buywell3 | |
23/7/2020 08:53 | POST REMOVED | buywell3 | |
23/7/2020 08:35 | POST REMOVED | buywell3 | |
25/6/2020 13:58 | Perpetual cash burner Never made a real bottom line profit for years - Probaly a bargepole stock - No dividends for ovr 5 years - revenue fallen for each of the last 3 years - Very illiquid so a few £1000 can shift price by high percentage either way -Should probably not be listed as costs of complying with AIM regulations- as a %age of market cap - horrific - | pugugly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions